Literature DB >> 3066396

Histiocytic lymphoma of breast responds to tamoxifen.

R R Millis1, L G Bobrow, R D Rubens, P G Isaacson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3066396      PMCID： PMC2246875          DOI： 10.1038/bjc.1988.314

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  Primary lymphoma of the breast.

Authors:  J M Dixon; A B Lumsden; A Krajewski; R A Elton; T J Anderson
Journal:  Br J Surg       Date:  1987-03       Impact factor: 6.939

2.  Tamoxifen in the treatment of refractory lymphoma.

Authors:  P Narasimhan
Journal:  N Engl J Med       Date:  1984-11-08       Impact factor: 91.245

3.  Malignant lymphoma of the breast. A study of 53 patients.

Authors:  S Brustein; D A Filippa; M Kimmel; P H Lieberman; P P Rosen
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

4.  Primary lymphoma of the breast.

Authors:  P U Telesinghe; P P Anthony
Journal:  Histopathology       Date:  1985-03       Impact factor: 5.087
  4 in total
  2 in total

1.  Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells.

Authors:  Y K Hoh; E H Lim; S O Ooi; O L Kon
Journal:  Experientia       Date:  1990-10-15

2.  Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.

Authors:  Myra Langendonk; Mathilde R W de Jong; Nienke Smit; Jonas Seiler; Bart Reitsma; Emanuele Ammatuna; Andor W J M Glaudemans; Anke van den Berg; Gerwin A Huls; Lydia Visser; Tom van Meerten
Journal:  Blood Cancer J       Date:  2022-03-07       Impact factor: 11.037
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.